SPYRE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.98 USD | +0.92% |
|
-12.75% | +53.25% |
| May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
| May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-21 | 2024-05-22 | 2024-05-23 | 2024-05-24 | |
|---|---|---|---|---|
| Last | 36.09 $ | 35.55 $ | 32.68 $ | 32.98 $ |
| Volume | 266 860 | 283 556 | 428 136 | 323 928 |
| Change | -2.12% | -1.50% | -8.07% | +0.92% |
| Opening | 36.30 | 35.97 | 35.75 | 32.68 |
| High | 37.35 | 37.75 | 36.79 | 34.00 |
| Low | 35.99 | 35.34 | 32.24 | 32.10 |
Performance
| 1 day | +0.92% | ||
| 1 week | -12.75% | ||
| Current month | -0.15% | ||
| 1 month | -1.73% | ||
| 3 months | +37.42% | ||
| 6 months | +198.73% | ||
| Current year | +53.25% | ||
| 1 year | +875.74% | ||
| 3 years | -80.51% | ||
| 5 years | -80.66% |
Volumes
marketsDaily volume
323 928
Estimated daily volume
323 928
Avg. Volume 20 sessions
290 912
Daily volume ratio
1.11
Avg. Volume 20 sessions USD
9 594 277.76
Record volume 1
10 228 381
Record volume 2
3 156 959
Record volume 3
2 233 298
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 328 546 993
Net sales (USD)
886 000
Number of employees
30
Sales / Employee (USD)
29 533
Free-Float
88.69 %
Free-Float capitalization (USD)
1 178 324 940
Average Daily Capital Traded
0.72%
Highs and lows
1 week
32.10
37.75
1 month
31.3940.49
Current year
18.5447.97
1 year
2.6647.97
3 years
2.66212.50
5 years
2.66284.50
10 years
2.66318.75
Indicators
Moving average 5 days
34.83
Moving average 20 days
35.64
Moving average 50 days
36.56
Moving average 100 days
31.70
Price spread / (MMA5)
+5.62%
Price spread / (MMA20)
+8.08%
Price spread / (MMA50)
+10.85%
Price spread / (MMA100)
-3.89%
STIM
RSI 9 days
33.90
RSI 14 days
40.43
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.92% | -12.75% | +53.25% | +875.74% | 1.33B | ||
| +1.36% | +2.64% | +12.30% | +38.47% | 118B | ||
| +0.45% | +0.28% | +12.15% | +35.86% | 106B | ||
| -2.07% | +7.00% | -8.14% | -7.90% | 23.4B | ||
| +0.66% | -0.65% | -1.69% | -9.73% | 21.78B | ||
| -4.86% | -5.61% | -10.60% | -31.68% | 18.09B | ||
| -1.25% | -4.79% | -41.25% | -35.25% | 16.72B | ||
| -2.22% | -11.65% | -15.33% | -35.54% | 15.97B | ||
| -0.79% | -2.03% | +5.80% | +52.82% | 14.03B | ||
| -2.89% | -6.03% | +28.03% | -2.65% | 11.67B | ||
| +4.84% | -8.30% | -31.18% | -34.41% | 7.55B | ||
| -0.72% | -1.83% | -2.52% | +23.74% | 7.53B | ||
| -0.74% | -7.79% | +9.49% | +40.41% | 7.48B | ||
| +0.75% | +7.67% | +3.54% | +45.30% | 7.48B | ||
| +1.92% | -6.34% | +237.18% | +194.46% | 6.92B | ||
| -3.42% | -11.52% | -57.97% | -71.04% | 6.62B | ||
| Average | -0.50% | -3.83% | +12.07% | +67.41% | ||
| Weighted average by Cap. | +0.02% | -0.47% | +7.60% | +24.39% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
4c0f7c.RcTWFRis6XKRXjLIRNxBOTbIMNAgUbj2Db4jadKWPFg.MoaRXCCY3QfWBkiFApggXnqtc5kWFoGmNcwXPKTzSyoqqIklQZuYI6Qcew
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 32.98 | 18,602 | 222,642 |
| 03:59:59 pm | 32.97 | 200 | 204,040 |
| 03:59:54 pm | 32.93 | 100 | 203,840 |
| 03:59:53 pm | 32.97 | 100 | 203,740 |
| 03:59:46 pm | 32.93 | 100 | 203,640 |
| 03:59:46 pm | 32.94 | 100 | 203,540 |
| 03:59:38 pm | 32.92 | 700 | 203,440 |
| 03:59:37 pm | 32.93 | 100 | 202,740 |
| 03:59:37 pm | 32.93 | 100 | 202,640 |
| 03:59:37 pm | 32.93 | 100 | 202,540 |
Monthly variations
Annual change
| 2024 | +53.25% | ||
| 2023 | +91.33% | ||
| 2022 | -90.53% | ||
| 2021 | -39.64% | ||
| 2020 | +3.01% | ||
| 2019 | +2.00% | ||
| 2018 | +38.45% | ||
| 2017 | +24.37% | ||
| 2016 | -63.72% |
- Stock Market
- Equities
- SYRE Stock
- Quotes Spyre Therapeutics, Inc.
